Patriot Financial Group Insurance Agency, LLC Puma Biotechnology, Inc. Call Options Transaction History

Patriot Financial Group Insurance Agency, LLC

$720 Million
Q3 2024

Call Options

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 Apr 30, 2024	SELL	$4.29 - $7.4 $81,081 - $139,860	-18,900 Reduced 75.6%	6,100 $32,000
Q4 2023 Jan 19, 2024	BUY	$2.23 - $4.49 $55,750 - $112,250	25,000 New	25,000 $108,000
Q2 2023 Jul 17, 2023	BUY	$2.6 - $3.58 $20,020 - $27,566	7,700 New	7,700 $27,000

Others Institutions Holding PBYI

# of Institutions

101

Shares Held

29M

Call Options Held

50.6K

Put Options Held

16.3K

Vanguard Group Inc Valley Forge, PA

3.64M
Shares

$11 Million
0.0% of portfolio
Black Rock Inc. New York, NY

3.57M
Shares

$10.8 Million
0.0% of portfolio
Frazier Life Sciences Management, L.P. Menlo Park, CA

3.06M
Shares

$9.25 Million
0.42% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

2.88M
Shares

$8.7 Million
0.0% of portfolio
Acadian Asset Management LLC Boston, MA

1.97M
Shares

$5.95 Million
0.02% of portfolio

View Full List

About PUMA BIOTECHNOLOGY, INC.

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $138M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

More about PBYI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Patriot Financial Group Insurance Agency, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Patriot Financial Group Insurance Agency, LLC with notifications on news.

Account